As the intrinsic tumor suppressive pathways of TGF-βs are largely dependent on Smads, a loss of Smads in cancer cells favors non-canonical TGF-β pathways that drive invasion, metastasis, aggressiveness, and therapeutic resistance [12]. The gene discussed is TGFB1; the disease is neoplasm.